We evaluated numbers of pan-cytokeratin+ CD45− cells in n = 40 patients with vulvar cancer treated with surgery alone (n = 22) or adjuvant RT (aRT) in addition to surgery (n = 18) as well as in n = 115 patients with cervical cancer treated with surgery alone (n = 57), surgery with aCRT (n = 36) and pCRT (n = 22). The gene discussed is PTPRC; the disease is vulva cancer.